Clinical Trials Directory

Trials / Unknown

UnknownNCT02052258

Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence

Oxytocin in Opiate Dependence: A Double-blind, Within-subjects, Placebo-controlled Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
Sponsor
MacDonald, Kai, M.D. · Individual
Sex
Male
Age
18 Years
Healthy volunteers

Summary

Opiate dependence is a serious problem, and oxytocin has many properties which make it attractive as a treatment for this type of substance dependence. This experiment will test the effects of oxytocin on a variety of brain-based processes in patients with opiate dependence. The investigators hypothesize that intranasal oxytocin in these conditions will enhance emotional processing and will have beneficial effects on stress responses in opiate-dependent patients.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin

Timeline

Start date
2013-01-01
Primary completion
2015-12-01
First posted
2014-02-03
Last updated
2014-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02052258. Inclusion in this directory is not an endorsement.